BeStock  
Stocks › Biotechnology › SLDB

Solid Biosciences SLDB

US equityMarket cap rank #3471Biotechnology
$6.85 −$0.07 (-1.01%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $6.85 0.00%
Open$6.76
Prev close$6.92
Day range$6.69 – $6.98
Volume744.7K
Market cap$734.49M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±12.8%last 3 reports
Closed higher0 of 30% of the time
Best reaction+0.0%
Worst reaction-21.4%

Stock move on the day after each report

+0.0%2020/Q3-21.4%2021/Q1-17.0%2022/Q1
QuarterReport dateTimingImplied moveActual moveVersus implied
2022/Q127 Apr 2022None±32.3%-16.98%Within range
2021/Q114 May 2021None±24.7%-21.40%Within range
2020/Q35 Nov 2020None–+0.00%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Fundamentals

Full statements →

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$57.38M-37.6% YoY
Net profit-$54.80M-38.8% YoY
Diluted EPS-$0.38+9.5% YoY
Free cash flow-$52.74M-39.6% YoY
Operating cash flow-$52.59M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-32.7MSep '24$-42.6MDec '24$-39.3MMar '25$-39.5MJun '25$-45.8MSep '25$-49.8MDec '25$-56.7MMar '26$-54.8MJun '26

Profitability & balance sheet

Return on equity-65.5%
Return on assets-56.8%
Return on invested capital-64.3%
Current ratio13.82
Liabilities / assets11.1%
Cash & investments$377.68M
Total debt$17.92M
Net cash (debt)$359.76M

Discussion

No comments yet — be the first to weigh in on SLDB.

Leave a comment

Scroll to Top